Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor (Part 1 and 2, Open, Non-randomised, 2 Parallel Groups) and Assessment of Ticagrelor Interaction Potential With Dabigatran (Part 3, Open, Randomised, Two-period Cross-over) in Healthy Male Subjects

Trial Profile

Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor (Part 1 and 2, Open, Non-randomised, 2 Parallel Groups) and Assessment of Ticagrelor Interaction Potential With Dabigatran (Part 3, Open, Randomised, Two-period Cross-over) in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Aug 2013

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Ticagrelor (Primary)
  • Indications Acute coronary syndromes; Embolism; Stroke; Venous thromboembolism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 27 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top